The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...